Home > Cashflow Statement > NATCO PHARMA

NATCO PHARMA
Cash Flow from Financing Activities

    Back to Cashflow Statement
NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Cash Flow from Financing Activities ₹298 Cr₹-211 Cr₹-247 Cr₹-363 Cr₹35 Cr

What is the latest Cash Flow from Financing Activities ratio of NATCO PHARMA ?

The latest Cash Flow from Financing Activities ratio of NATCO PHARMA is ₹298 Cr based on Mar2026 Consolidated results.
Year Cash Flow from Financing Activities
Mar2026₹298 Cr
Mar2025₹-211 Cr
Mar2024₹-247 Cr
Mar2023₹-363 Cr
Mar2022₹35 Cr

How is Cash Flow from Financing Activities of NATCO PHARMA Trending?

Years Cash Flow from Financing Activities % Change
Mar2026 ₹298 Cr
Positive
Mar2025 ₹-211 Cr
Negative
Mar2024 ₹-247 Cr
Negative
Mar2023 ₹-363 Cr
Negative
Mar2022 ₹35 Cr -

Compare Cash Flow from Financing Activities of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹15,579.3 Cr -1.3% -4.9% -3.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹422,283.0 Cr -0.1% -6.5% 3.8% Stock Analytics
DIVIS LABORATORIES ₹251,611.0 Cr -0.2% -5.5% 35.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹175,182.0 Cr 0.4% -8.2% 25.2% Stock Analytics
CIPLA ₹109,063.0 Cr 1.7% -2% -15.3% Stock Analytics
DR REDDYS LABORATORIES ₹108,926.0 Cr 4.9% 7.7% -2.5% Stock Analytics


NATCO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

-1.3%

-4.9%

-3.3%

SENSEX

-0.3%

-1.6%

-12.3%


You may also like the below Video Courses